Skip to content
AnalystLens

AGILENT TECHNOLOGIES, INC. 8-K Report, Regulation FD Disclosure (Jan 11, 2021)

Reports
Regulation FD
Filing Date
Filed January 11, 2021
Period End
January 11, 2021
Security
A
In the record · 2016–202610-K1010-Q338-K115

A filed 10 annual reports (10-K), 33 quarterly reports (10-Q) and 115 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Jul ’17Jul ’17
  2. Leadership change8-K · Jan ’20Jan ’20
  3. Material agreement8-K · Apr ’22Apr ’22
  4. Leadership change8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed January 11, 2021. Cited figures are marked; the original filing is the authoritative source.

Agilent Technologies, Inc. (Agilent) announced an improved financial outlook for its fiscal first quarter ending January 31, 2021, exceeding its previously provided guidance.

The company now anticipates core revenue growth to be in the high single digits, a significant increase from the previously guided range of 3.5%a to 4.5%. This upward revision is attributed to broad-based strong growth across all three business segments and most markets, driven by customers utilizing their year-end budgets. This positive development will be further discussed by Agilent's CEO at the JP Morgan Healthcare Conference.

While this forecast indicates strong performance, investors should note that Agilent will provide a more comprehensive update to its fiscal year 2021 revenue and earnings guidance with its first-quarter financial release. The company also reminds stakeholders that actual results may differ due to ongoing market uncertainties and various risks detailed in its SEC filings.

Key Highlights

  1. Agilent raises Q1 fiscal 2021 core revenue growth expectations to high single digits, up from 3.5%-4.5% previously guided.
  2. Strong, broad-based growth across all three business segments and most markets is driving the improved outlook.
  3. Customer utilization of year-end budgets is a key factor contributing to the stronger-than-expected performance.
  4. CEO Mike McMullen will discuss the improved outlook at the JP Morgan Healthcare Conference.
  5. A full update to fiscal year 2021 revenue and earnings guidance will be provided with the Q1 financial release.
  6. The company emphasizes that actual results could differ due to continued market uncertainty and inherent risks.
  7. The report clarifies that 'core revenue growth' excludes currency, acquisitions, and divestitures, and is a non-GAAP measure.

Frequently Asked Questions

  1. What is the primary reason for Agilent's improved Q1 fiscal 2021 revenue guidance?

    The improved outlook is driven by broad-based strong growth across all three of Agilent's business segments and most markets. A significant contributing factor is the utilization of year-end budgets by customers.

  2. How does the new Q1 guidance compare to the previous guidance?

    Agilent now expects core revenue growth to be at least in the high single digits, a substantial increase from the previously announced guidance of 3.5% to 4.5% for the fiscal first quarter ending January 31, 2021.

  3. When will investors receive an updated outlook for the full fiscal year 2021?

    Agilent plans to provide an update to its fiscal year 2021 revenue and earnings guidance as part of its first-quarter financial results release. No specific date for this release was provided in this filing.

  4. What does 'core revenue growth' mean, and is it a GAAP measure?

    'Core revenue growth' excludes the impact of currency fluctuations and acquisitions and divestitures within the past 12 months. It is a non-GAAP measure, meaning it is not prepared in accordance with U.S. Generally Accepted Accounting Principles.